NasdaqGS - Nasdaq Real Time Price USD

Olema Pharmaceuticals, Inc. (OLMA)

4.8000
+0.0900
+(1.91%)
At close: May 19 at 4:00:00 PM EDT
4.8000
0.00
(0.00%)
After hours: May 19 at 4:05:17 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
142,792
142,258
104,961
106,988
71,491
Operating Income
-142,792
-142,258
-104,961
-106,988
-71,491
Net Non Operating Interest Income Expense
13,854
12,682
8,325
2,228
442
Other Income Expense
45
102
-19
-27
-47
Pretax Income
-128,893
-129,474
-96,655
-104,787
-71,096
Net Income Common Stockholders
-128,893
-129,474
-96,655
-104,787
-71,096
Diluted NI Available to Com Stockholders
-128,893
-129,474
-96,655
-104,787
-71,096
Basic EPS
-2.00
--
-2.14
-2.62
-1.80
Diluted EPS
-2.00
--
-2.14
-2.62
-1.80
Basic Average Shares
66,206.4970
--
45,247.0980
39,995.4600
39,524.2720
Diluted Average Shares
66,206.4970
--
45,247.0980
39,995.4600
39,524.2720
Total Operating Income as Reported
-142,792
-142,258
-104,961
-106,988
-71,491
Total Expenses
142,792
142,258
104,961
106,988
71,491
Net Income from Continuing & Discontinued Operation
-128,893
-129,474
-96,655
-104,787
-71,096
Normalized Income
-128,893
-129,474
-96,655
-104,787
-71,096
Interest Income
13,854
12,682
8,325
2,228
442
Interest Expense
--
--
--
--
0
Net Interest Income
13,854
12,682
8,325
2,228
442
EBIT
-142,792
-142,258
-104,961
-106,988
-71,491
EBITDA
-142,359
-141,865
-104,584
-106,631
-71,328
Reconciled Depreciation
433
393
377
357
163
Net Income from Continuing Operation Net Minority Interest
-128,893
-129,474
-96,655
-104,787
-71,096
Normalized EBITDA
-142,359
-141,865
-104,584
-106,631
-71,328
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/19/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CGEM Cullinan Therapeutics, Inc.
7.71
+2.80%
 
ORIC ORIC Pharmaceuticals, Inc.
5.14
+8.67%
 
GBIO Generation Bio Co.
0.4018
+5.38%
 
PRAX Praxis Precision Medicines, Inc.
37.35
+0.89%
 
FDMT 4D Molecular Therapeutics, Inc.
3.8000
+10.47%
 
ERAS Erasca, Inc.
1.2300
-4.28%
 
DSGN Design Therapeutics, Inc.
3.5300
+0.57%
 
ITOS iTeos Therapeutics, Inc.
8.41
+7.68%
 
ZNTL Zentalis Pharmaceuticals, Inc.
1.2500
-0.79%
 
COGT Cogent Biosciences, Inc.
4.9800
+2.05%